Clinical Trial Update: Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer [NA]

View source ↗

Summary

A terminated clinical trial investigating how gut microbiome and gastrointestinal toxicities influence response to neoadjuvant chemotherapy in advanced breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Arkansas | Conditions: Breast Cancer | NA | Status: TERMINATED | Results posted: 2021-09-24